These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20971583)

  • 1. Genome-wide association scan of Dupuytren's disease.
    Ojwang JO; Adrianto I; Gray-McGuire C; Nath SK; Sun C; Kaufman KM; Harley JB; Rayan GM
    J Hand Surg Am; 2010 Dec; 35(12):2039-45. PubMed ID: 20971583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.
    Bayat A; Alansar A; Hajeer AH; Shah M; Watson JS; Stanley JK; Ferguson MW; Ollier WE
    J Hand Surg Br; 2002 Feb; 27(1):47-9. PubMed ID: 11895345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling and Dupuytren's disease.
    Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
    N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
    Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
    Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT2 locus is involved in genetic susceptibility of Peyronie's disease.
    Dolmans GH; Werker PM; de Jong IJ; Nijman RJ; ; Wijmenga C; Ophoff RA
    J Sex Med; 2012 May; 9(5):1430-4. PubMed ID: 22489561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians.
    Brown JJ; Ollier W; Thomson W; Bayat A
    Tissue Antigens; 2008 Aug; 72(2):166-70. PubMed ID: 18721277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease.
    Bayat A; Stanley JK; Watson JS; Ferguson MW; Ollier WE
    Br J Plast Surg; 2003 Jun; 56(4):328-33. PubMed ID: 12873459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
    Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E
    Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
    Shih B; Tassabehji M; Watson JS; Bayat A
    Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Dupuytren's disease.
    Michou L; Lermusiaux JL; Teyssedou JP; Bardin T; Beaudreuil J; Petit-Teixeira E
    Joint Bone Spine; 2012 Jan; 79(1):7-12. PubMed ID: 21803632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
    Truong T; Hung RJ; Amos CI; Wu X; Bickeböller H; Rosenberger A; Sauter W; Illig T; Wichmann HE; Risch A; Dienemann H; Kaaks R; Yang P; Jiang R; Wiencke JK; Wrensch M; Hansen H; Kelsey KT; Matsuo K; Tajima K; Schwartz AG; Wenzlaff A; Seow A; Ying C; Staratschek-Jox A; Nürnberg P; Stoelben E; Wolf J; Lazarus P; Muscat JE; Gallagher CJ; Zienolddiny S; Haugen A; van der Heijden HF; Kiemeney LA; Isla D; Mayordomo JI; Rafnar T; Stefansson K; Zhang ZF; Chang SC; Kim JH; Hong YC; Duell EJ; Andrew AS; Lejbkowicz F; Rennert G; Müller H; Brenner H; Le Marchand L; Benhamou S; Bouchardy C; Teare MD; Xue X; McLaughlin J; Liu G; McKay JD; Brennan P; Spitz MR
    J Natl Cancer Inst; 2010 Jul; 102(13):959-71. PubMed ID: 20548021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
    Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
    J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.
    Major M; Freund MK; Burch KS; Mancuso N; Ng M; Furniss D; Pasaniuc B; Ophoff RA
    Genet Epidemiol; 2019 Sep; 43(6):629-645. PubMed ID: 31087417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide high-resolution screening in Dupuytren's disease reveals common regions of DNA copy number alterations.
    Shih BB; Tassabehji M; Watson JS; McGrouther AD; Bayat A
    J Hand Surg Am; 2010 Jul; 35(7):1172-1183.e7. PubMed ID: 20561756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
    Becker K; Siegert S; Toliat MR; Du J; Casper R; Dolmans GH; Werker PM; Tinschert S; Franke A; Gieger C; Strauch K; Nothnagel M; Nürnberg P; Hennies HC;
    PLoS One; 2016; 11(7):e0158101. PubMed ID: 27467239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
    Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN
    PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family.
    Hu FZ; Nystrom A; Ahmed A; Palmquist M; Dopico R; Mossberg I; Gladitz J; Rayner M; Post JC; Ehrlich GD; Preston RA
    Clin Genet; 2005 Nov; 68(5):424-9. PubMed ID: 16207209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants.
    Riesmeijer SA; Werker PMN; Nolte IM
    Eur J Hum Genet; 2019 Dec; 27(12):1876-1884. PubMed ID: 31363186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.